Venu Holding Corporation (NYSEAMERICAN:VENU – Get Free Report) Director Thomas Finke acquired 4,361 shares of the business’s stock in a transaction dated Tuesday, December 30th. The stock was purchased at an average price of $7.80 per share, with a total value of $34,015.80. Following the completion of the transaction, the director directly owned 29,961 shares of the company’s stock, valued at $233,695.80. This trade represents a 17.04% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Venu Stock Performance
Venu stock opened at $8.25 on Thursday. Venu Holding Corporation has a 1-year low of $7.05 and a 1-year high of $18.17. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $353.51 million, a PE ratio of -6.82 and a beta of 3.40. The firm’s 50 day simple moving average is $9.88 and its 200 day simple moving average is $12.09.
Venu (NYSEAMERICAN:VENU – Get Free Report) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.06. The firm had revenue of $5.38 million during the quarter, compared to the consensus estimate of $7.43 million. Venu had a negative net margin of 238.68% and a negative return on equity of 26.71%.
Hedge Funds Weigh In On Venu
About Venu
Venu Holding Corporation is a premier hospitality and live music company dedicated to crafting luxury, experience-driven entertainment destinations. Venu Holding Corporation is based in COLORADO SPRINGS, Colo.
Further Reading
- Five stocks we like better than Venu
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Do not delete, read immediately
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Venu Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venu and related companies with MarketBeat.com's FREE daily email newsletter.
